APOTHEEK GILAIN: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
APOTHEEK GILAIN
Largest movements
- Intangible fixed assets -€50,574
down €50,574 (-18.0%), from €280,458 to €229,884
- Tangible fixed assets -€19,508
down €19,508 (-20.7%), from €94,265 to €74,757
- Cash -€11,426
down €11,426 (-6.5%), from €174,480 to €163,054
mainly Trade debts (-€54,011) and Debts after one year (-€51,419)
- Trade debts -€54,011
down €54,011 (-22.4%), from €241,157 to €187,146
- Debts after one year -€51,419
down €51,419 (-22.3%), from €230,145 to €178,727
- Profit (loss) carried forward +€35,550
up €35,550 (+44.2%), from -€80,424 to -€44,874
- Other debts -€9,995
down €9,995 (-17.2%), from €58,070 to €48,075
- Gross operating margin +€28,553
up €28,553 (+29.9%), from €95,429 to €123,982
- Financial charges +€21,061
up €21,061, from -€4,733 to €16,327
- Financial income -€2,329
down €2,329 (-90.6%), from €2,571 to €242
of which Non-recurring financial income: -€2,000
- Depreciation -€1,355
down €1,355 (-1.9%), from €71,437 to €70,082
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €785,256 | €705,776 | -€79,481 | -10.1% |
| Fixed assets | 21/28 | €374,723 | €304,641 | -€70,082 | -18.7% |
| Intangible fixed assets | 21 | €280,458 | €229,884 | -€50,574 | -18.0% |
| Tangible fixed assets | 22/27 | €94,265 | €74,757 | -€19,508 | -20.7% |
| Plant, machinery and equipment | 23 | €94,265 | €74,757 | -€19,508 | -20.7% |
| Current assets | 29/58 | €410,533 | €401,135 | -€9,398 | -2.3% |
| Stocks and contracts in progress | 3 | €134,543 | €140,206 | +€5,663 | +4.2% |
| Stocks | 30/36 | €134,543 | €140,206 | +€5,663 | +4.2% |
| Amounts receivable within one year | 40/41 | €39,459 | €34,146 | -€5,313 | -13.5% |
| Trade receivables | 40 | €18,864 | €14,153 | -€4,710 | -25.0% |
| Other amounts receivable | 41 | €20,595 | €19,993 | -€602 | -2.9% |
| Cash at bank and in hand | 54/58 | €174,480 | €163,054 | -€11,426 | -6.5% |
| Deferred charges and accrued income | 490/1 | €62,052 | €63,729 | +€1,677 | +2.7% |
| Total equity and liabilities | 10/49 | €785,256 | €705,776 | -€79,481 | -10.1% |
| Equity | 10/15 | €204,576 | €240,126 | +€35,550 | +17.4% |
| Contributions | 10/11 | €285,000 | €285,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€80,424 | -€44,874 | +€35,550 | +44.2% |
| Amounts payable | 17/49 | €580,680 | €465,649 | -€115,031 | -19.8% |
| Amounts payable after more than one year | 17 | €230,145 | €178,727 | -€51,419 | -22.3% |
| Financial debts | 170/4 | €230,145 | €178,727 | -€51,419 | -22.3% |
| Amounts payable within one year | 42/48 | €350,247 | €286,639 | -€63,608 | -18.2% |
| Current portion of amounts payable after more than one year | 42 | €51,020 | €51,419 | +€398 | +0.8% |
| Trade debts | 44 | €241,157 | €187,146 | -€54,011 | -22.4% |
| Suppliers | 440/4 | €241,157 | €187,146 | -€54,011 | -22.4% |
| Other amounts payable | 47/48 | €58,070 | €48,075 | -€9,995 | -17.2% |
| Accrued charges and deferred income | 492/3 | €288 | €284 | -€4 | -1.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €71,437 | €70,082 | -€1,355 | -1.9% |
| Other operating charges | 640/8 | €2,787 | €2,264 | -€523 | -18.8% |
| Gross operating margin | 9900 | €95,429 | €123,982 | +€28,553 | +29.9% |
| Operating profit (loss) | 9901 | €21,205 | €51,636 | +€30,431 | +144% |
| Financial income | 75/76B | €2,571 | €242 | -€2,329 | -90.6% |
| Recurring financial income | 75 | €571 | €242 | -€329 | -57.6% |
| Non-recurring financial income | 76B | €2,000 | - | -€2,000 | |
| Financial charges | 65/66B | -€4,733 | €16,327 | +€21,061 | |
| Recurring financial charges | 65 | -€4,733 | €16,327 | +€21,061 | |
| Profit (loss) for the period before taxes | 9903 | €28,509 | €35,550 | +€7,041 | +24.7% |
| Profit (loss) for the period | 9904 | €28,509 | €35,550 | +€7,041 | +24.7% |
| Profit (loss) for the period to be appropriated | 9905 | €28,509 | €35,550 | +€7,041 | +24.7% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 24 October 2026 via checked.be.